Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2015 18:30 ET | Source: Adverum Biotechnologies, Inc.

Avalanche Biotechnologies Presents Three Posters at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

MENLO PARK, Calif., May 14, 2015 (GLOBE NEWSWIRE) -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a clinical-stage biopharmaceutical company committed to improving or preserving the sight of people...
May 13, 2015 07:00 ET | Source: Adverum Biotechnologies, Inc.

Avalanche Biotechnologies, Inc. Reports First Quarter 2015 Financial Results

MENLO PARK, Calif., May 13, 2015 (GLOBE NEWSWIRE) -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a clinical-stage biopharmaceutical company committed to improving or preserving the sight of people...
April 28, 2015 07:00 ET | Source: Adverum Biotechnologies, Inc.

Avalanche Biotechnologies to Present at Upcoming Scientific Meetings

MENLO PARK, Calif., April 28, 2015 (GLOBE NEWSWIRE) -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a clinical-stage biopharmaceutical company committed to improving or preserving the sight of...
March 25, 2015 07:00 ET | Source: Adverum Biotechnologies, Inc.

Avalanche Biotechnologies and the University of Washington Enter Into Exclusive License Agreement to Develop Gene Therapy Medicines to Treat Color Blindness

Vision Experts Jay and Maureen Neitz Join Company's Scientific Advisory Board Company Launches www.colorvisionawareness.com to Provide More Information for People with Color Blindness MENLO...
March 18, 2015 09:00 ET | Source: Adverum Biotechnologies, Inc.

Avalanche Biotechnologies to Host Analyst and Investor Day on March 25, 2015

MENLO PARK, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a clinical-stage biotechnology company focused on discovering and developing novel gene therapies...
March 05, 2015 09:00 ET | Source: Adverum Biotechnologies, Inc.

Avalanche Biotechnologies, Inc. Reports Fourth Quarter and Fiscal 2014 Financial Results

MENLO PARK, Calif., March 5, 2015 (GLOBE NEWSWIRE) -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a clinical-stage biotechnology company focused on discovering and developing novel gene therapies...
February 25, 2015 07:00 ET | Source: Adverum Biotechnologies, Inc.

Avalanche Biotechnologies to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a clinical-stage biotechnology company focused on discovering and developing novel gene therapies...
January 08, 2015 09:00 ET | Source: Adverum Biotechnologies, Inc.

Avalanche Biotechnologies Prices Public Offering of $141.6 Million of Common Stock

MENLO PARK, Calif., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to...
January 05, 2015 16:01 ET | Source: Adverum Biotechnologies, Inc.

Avalanche Biotechnologies Announces Proposed Public Offering of Common Stock and Partial Release of Lock-Up Agreements in Connection Therewith

MENLO PARK, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to...
November 26, 2014 09:00 ET | Source: Adverum Biotechnologies, Inc.

Avalanche Biotechnologies to Present at the 26th Annual Piper Jaffray Healthcare Conference

MENLO PARK, Calif., Nov. 26, 2014 (GLOBE NEWSWIRE) -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a clinical-stage biotechnology company focused on discovering and developing novel gene therapies...